Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. G. Giles
Impact of Altered Growth Factor Signalling on Endocrine Response in Breast Cancer and the Transition From ER+ to ER[minus Sign] Disease
Breast Cancer Online
Related publications
Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines
PLoS ONE
Multidisciplinary
Neoadjuvant Palbociclib on ER+ Breast Cancer (N007): Clinical Response and EndoPredict Value
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
Cancers
Cancer Research
Oncology
Gene Expression-Based Predictive Markers for Paclitaxel Treatment in ER+ and ER− Breast Cancer
Frontiers in Genetics
Genetics
Molecular Medicine
Loss of TBK1 Induces Epithelial-Mesenchymal Transition in the Breast Cancer Cells by ER Downregulation
Cancer Research
Cancer Research
Oncology
Overexpression of CXXC5 Is a Strong Poor Prognostic Factor in ER+ Breast Cancer
Oncology Letters
Cancer Research
Oncology
Estrogen Therapy Induces an Unfolded Protein Response to Drive Cell Death in ER + Breast Cancer
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Distinct P53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers
Clinical Cancer Research
Cancer Research
Oncology
Evaluating an ER Degrader for Breast Cancer
Cancer Discovery
Oncology
